Lofexidine: all 33 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid WithdrawalRecruitingNCT05995535Phase 2
- Assessing a Clinically-meaningful Opioid Withdrawal PhenotypeRecruitingNCT05027919Phase 2
- A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for ReconstitutionCompletedNCT04188730Phase 1Results posted
- Lofexidine for Adults Undergoing Lumbar Spine SurgeryCompletedNCT04126083Phase 4Results posted
- Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of WithdrawalTerminatedNCT04070157Phase 2Results posted
- Lofexidine for Management of Opioid Withdrawal With XR-NTX TreatmentCompletedNCT04056182Phase 2Results posted
- Impact of Lofexidine on Stress, Craving and Opioid UseCompletedNCT03718065Phase 2Results posted
- Open-Label, Safety Study of LofexidineCompletedNCT02363998Phase 3Results posted
- Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid WithdrawalCompletedNCT01863186Phase 3Results posted
- Combined Pharmacotherapy for Cannabis DependencyCompletedNCT01020019Phase 2/3Results posted
- Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1CompletedNCT00142909Phase 2Results posted
- A Pharmacokinetic, Safety, and Tolerability Study of LUCEMYRA in the Treatment of Opioid Withdrawal Management in Adolescent SubjectsWithdrawnNCT06711640Phase 1
- Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol AbuseCompletedNCT05569031Phase 4
- Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in VeteransCompletedNCT04360681Phase 2
- Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy VolunteersCompletedNCT02681198Phase 1
- Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy SubjectsCompletedNCT02446002Phase 1
- Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired SubjectsCompletedNCT02318836Phase 1
- Single-dose Pharmacokinetics and Safety of Oral Lofexidine in Renally-Impaired SubjectsCompletedNCT02313103Phase 1
- Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained PatientsCompletedNCT01820442Phase 1
- Lofexidine for Inpatient Opiate Detox in SingaporeCompletedNCT01675648Phase 4
- Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained PatientsCompletedNCT01650649Phase 1
- Lofexidine Mass Balance in VolunteersCompletedNCT01629446Phase 1
- Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained PatientsCompletedNCT01558934Phase 1
- Lofexidine Food Effect Study in Healthy VolunteersCompletedNCT01437306Phase 1
- Lofexidine ADME & Mass Balance in VolunteersCompletedNCT01310296Phase 1
- Interactions Between Intravenous (IV) Cocaine and LofexidineTerminatedNCT01148992Phase 1
- Effect of Lofexidine and Oral THC on Marijuana Withdrawal and RelapseCompletedNCT00373503Phase 2
- Lofexidine for Inpatient Opiate DetoxCompletedNCT00235729Phase 3
- Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1CompletedNCT00218530Phase 1
- Lofexidine for Opiate Withdrawal - 1CompletedNCT00032942Phase 3
- Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7CompletedNCT00000358Phase 1
- Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3CompletedNCT00000354Phase 1
- Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10CompletedNCT00000345Phase 1